FindTrial
Sign In

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular block in robotic urologic surgery: a retrospective cohort study with propensity score matching

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular block in robotic urologic surgery: a retrospective cohort study with propensity score matching

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076844
Enrollment
Unknown
Registered
2023-10-22
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reversal of neuromuscular block

Interventions

Sugammadex Group:NA
Neostigmine Group:NA

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Age > 18 years old; ? Patients undergoing general anesthesia for robotic urologic surgery

Exclusion criteria

Exclusion criteria: ? Incomplete medical records data; ? Patients whose tracheal tube were not removed in the operating room after surgery and were transferred to ICU.

Design outcomes

Primary

MeasureTime frame
Total expenses in hospital;—

Secondary

MeasureTime frame
Surgical duration;Duration from extubation to leaving the operating room;Duration from surgical end to extubation;Duration of PACU stay;Postoperative complications;Duration of postoperative hospital stay;—

Countries

China

Contacts

Public ContactZhang Hong

Peking University First Hospital

zhanghong40@hotmail.com+86 139 1010 4660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026